BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 32604955)

  • 1. Neuropathophysiology, Genetic Profile, and Clinical Manifestation of Mucolipidosis IV-A Review and Case Series.
    Jezela-Stanek A; Ciara E; Stepien KM
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32604955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The neurogenetics of mucolipidosis type IV.
    Altarescu G; Sun M; Moore DF; Smith JA; Wiggs EA; Solomon BI; Patronas NJ; Frei KP; Gupta S; Kaneski CR; Quarrell OW; Slaugenhaupt SA; Goldin E; Schiffmann R
    Neurology; 2002 Aug; 59(3):306-13. PubMed ID: 12182165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucolipin 1: endocytosis and cation channel--a review.
    Bach G
    Pflugers Arch; 2005 Oct; 451(1):313-7. PubMed ID: 15570434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The molecular basis of mucolipidosis type IV.
    Slaugenhaupt SA
    Curr Mol Med; 2002 Aug; 2(5):445-50. PubMed ID: 12125810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucolipidosis type IV: the importance of functional lysosomes for efficient autophagy.
    Vergarajauregui S; Puertollano R
    Autophagy; 2008 Aug; 4(6):832-4. PubMed ID: 18635948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shared facial phenotype of patients with mucolipidosis type IV: A clinical observation reaffirmed by next generation phenotyping.
    Pode-Shakked B; Finezilber Y; Levi Y; Liber S; Fleischer N; Greenbaum L; Raas-Rothschild A
    Eur J Med Genet; 2020 Jul; 63(7):103927. PubMed ID: 32298796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autophagic dysfunction in mucolipidosis type IV patients.
    Vergarajauregui S; Connelly PS; Daniels MP; Puertollano R
    Hum Mol Genet; 2008 Sep; 17(17):2723-37. PubMed ID: 18550655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucolipidosis type IV: an update.
    Wakabayashi K; Gustafson AM; Sidransky E; Goldin E
    Mol Genet Metab; 2011 Nov; 104(3):206-13. PubMed ID: 21763169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel compound heterozygous MCOLN1 mutations identified in a Japanese girl with severe developmental delay and thin corpus callosum.
    Yamaguchi N; Ban K; Suzuki A; Nakamura Y; Kato K; Muramatsu H; Okuno Y; Hattori A; Kaname T; Takahashi Y; Saitoh S
    Brain Dev; 2020 Mar; 42(3):298-301. PubMed ID: 31899079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucolipidosis type IV in a Turkish boy associated with a novel MCOLN1 mutation.
    Tüysüz B; Goldin E; Metin B; Korkmaz B; Yalçinkaya C
    Brain Dev; 2009 Oct; 31(9):702-5. PubMed ID: 19006653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chaperone-mediated autophagy is defective in mucolipidosis type IV.
    Venugopal B; Mesires NT; Kennedy JC; Curcio-Morelli C; Laplante JM; Dice JF; Slaugenhaupt SA
    J Cell Physiol; 2009 May; 219(2):344-53. PubMed ID: 19117012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term observation of a Japanese mucolipidosis IV patient with a novel homozygous p.F313del variant of MCOLN1.
    Hayashi T; Hosono K; Kubo A; Kurata K; Katagiri S; Mizobuchi K; Kurai M; Mamiya N; Kondo M; Tachibana T; Saitsu H; Ogata T; Nakano T; Hotta Y
    Am J Med Genet A; 2020 Jun; 182(6):1500-1505. PubMed ID: 32220057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cation channel activity of mucolipin-1: the effect of calcium.
    Cantiello HF; Montalbetti N; Goldmann WH; Raychowdhury MK; González-Perrett S; Timpanaro GA; Chasan B
    Pflugers Arch; 2005 Oct; 451(1):304-12. PubMed ID: 16133264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LAPTMs regulate lysosomal function and interact with mucolipin 1: new clues for understanding mucolipidosis type IV.
    Vergarajauregui S; Martina JA; Puertollano R
    J Cell Sci; 2011 Feb; 124(Pt 3):459-68. PubMed ID: 21224396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucolipidosis type IV is caused by mutations in a gene encoding a novel transient receptor potential channel.
    Sun M; Goldin E; Stahl S; Falardeau JL; Kennedy JC; Acierno JS; Bove C; Kaneski CR; Nagle J; Bromley MC; Colman M; Schiffmann R; Slaugenhaupt SA
    Hum Mol Genet; 2000 Oct; 9(17):2471-8. PubMed ID: 11030752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucolipidosis Type IV in Omani Families with a Novel
    Al-Alawi B; Harikrishna B; Al-Thihli K; Al Zuhabi S; Ganesh A; Al Hashami Z; Al Dhamhmani Z; Zadjali R; Al Riyami NB; Zadjali F
    Genes (Basel); 2022 Jan; 13(2):. PubMed ID: 35205297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular pathophysiology of mucolipidosis type IV: pH dysregulation of the mucolipin-1 cation channel.
    Raychowdhury MK; González-Perrett S; Montalbetti N; Timpanaro GA; Chasan B; Goldmann WH; Stahl S; Cooney A; Goldin E; Cantiello HF
    Hum Mol Genet; 2004 Mar; 13(6):617-27. PubMed ID: 14749347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucolipidosis type IV and the mucolipins.
    Bach G; Zeevi DA; Frumkin A; Kogot-Levin A
    Biochem Soc Trans; 2010 Dec; 38(6):1432-5. PubMed ID: 21118102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucolipidosis type IV.
    Bach G
    Mol Genet Metab; 2001 Jul; 73(3):197-203. PubMed ID: 11461186
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.